CF Industries Holdings, Inc. (NYSE:CF) recorded -3.56% downtrend from the beginning of this year till date. The 12-month potential price target for CF Industries Holdings, Inc. is set at $54.28. This target means that the stock has an upside potential to increase by 29.36% from the current trading price. The stock of CF went up by $0.1 now trading at $41.96. Their shares witnessed a 17.54% increase from the 52-week low price of $35.7 they recorded on 2018-04-04. Even though it is still -34.68% behind the $56.51 high touched on 2018-10-04. The last few days have been rough for the stock, as its price has decreased by -1.64% during the week. It has also performed poorly over the past three months, as it lost around -21.64% while it has so far climbed around 12.01% during the course of a year.
When giving their opinion, around 55.56% of Wall Street analysts, which represents 10 out of 18 rated the stock as a Buy. 8 brokerage firms of the remaining 44.44% rated the stock as a Hold with 0 analyst rating it as a sell. Overall, the number of aggregate CF shares held by institutional investors represents 99.6% of total shares. 72 institutions entered new CF Industries Holdings, Inc. (NYSE:CF) positions, 233 added to their existing positions in these shares, 260 lowered their positions, and 61 exited their positions entirely.
CF Industries Holdings, Inc. (CF) trade volume has increased by 9.59% as around 3,229,242 shares were sold when compared with its 50-day average volume of traded shares which is 2,946,728. At the moment, CF is witnessing a downtrend, as it is trading -2.01% below its 20-day SMA, -1.5% below its 50-day SMA, and -7.94% below its 200-day SMA. The company runs an ROE of roughly 19.9%, with financial analysts predicting that their earnings per share growth will be around 0% per annum for the next five year. This will be compared to the -16% decrease witnessed over the past five years.
The first technical resistance point for CF Industries Holdings, Inc. (NYSE:CF) will likely come at $42.4, marking a 1.04% premium to the current level. The second resistance point is at $42.85, about 2.08% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $40.94, the lower end of the range. CF’s 14-day MACD is -0.79 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 45.41, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 31.48 percent, which is low when compared to that of the 50-day’s 38.73 percent.
The shares of Cardinal Health, Inc. (NYSE:CAH) has increased by 0.99%, and now trading at $53.19 on the Wall Street in the intra-day deal, with their shares traded now around 2,514,899. This is a decline of -1,015,531 shares over the average 3,530,430 shares that were traded daily over the last three months. The stock that is trading at $53.19 went higher by 26.13% from its 52-week low of $42.17 that it attained back on 2018-12-26. The stock recorded a 52-week high of $73.23 nearly 336 days ago on 2018-03-13.
CAH stock has performed well over the past 30 days, as it added 11.77% while its price climbed by 19.26% year-to-date (YTD). Looking at the last few days, it has been good for the stock, as it rose 6.57% over the last week. The stock’s 12-month potential target price is now at $53.47. This means that the stock price might likely increase by 0.53% from its current trading price.2 out of 17 Wall Street analysts which represents 11.76% rated the stock as a buy while the remaining 76.47 rated it as a hold, with 11.76 of analysts rating it as a sell.
Cardinal Health, Inc. (NYSE:CAH) has been utilizing an ROE that is roughly -0.6%, with stock analysts predicting that the company’s EPS for the next five years will go up by 6.3% per year, following the -32.5% drop that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 7.68% above its 20-day SMA, 8% above its 50-day SMA, and 2.46% above its 200-day SMA. In percentage terms, the aggregate Cardinal Health, Inc. shares held by institutional investors is 92.8%. 69 institutions jumped in to acquire Cardinal Health, Inc. (CAH) fresh stake, 300 added to their current holdings in these shares, 352 lowered their positions, and 92 left no stake in the company.
The stock’s 9-day MACD is 2.36 and this positive figure indicates an upward trading trend. The company’s 9-day RSI score is 69.57, which shows that its stock has been overbought. The 20-day historical volatility for the shares stand at 33.55 percent, which is more when compared to that of the 50-day’s 31.75 percent. On the daily chart, we see that the stock could reach the first level of resistance at $53.57, sporting a 0.71% premium to the current level. The next resistance point is at $53.96, representing nearly 1.43% premium to the current market price of Cardinal Health, Inc. (CAH). On the other hand, failure to breach the immediate hurdles can drag it down to $51.74, the lower end of the range.